Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement

Journal of the American College of Cardiology

Volumn 32, Issue 7, 1998, Pages 1866-1873

  Elezi, Shpend ^a   Kastrati, Adnan ^a   Pache, Jürgen ^a   Wehinger, Anne ^a   Hadamitzky, Martin ^a   Dirschinger, Josef ^a   Neumann, Franz Josef ^a   Schömig, Albert ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RESTENOSIS; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REGRESSION ANALYSIS; STENTS; TREATMENT OUTCOME;

EID: 0032406132     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00467-7     Document Type: Article

References (37)

1. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA. 241:1979;2035-2038.
2. Stamler J., Vaccaro O., Neaton J.D., Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 16:1993;434-444.
3. Uusitupa M.I., Niskanen L.K., Siitonen O., Voutilainen E., Pyorala K. 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation. 82:1990;27-36.
4. Kip K.E., Faxon D.P., Detre K.M., Yeh W., Kelsey S.F., Currier J.W. Coronary angioplasty in diabetic patients The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry . Circulation. 94:1996;1818-1825.
5. Stein B., Weintraub W.S., Gebhart S.P., et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation. 91:1995;979-989.
6. Barsness G.W., Peterson E.D., Ohman E.M., et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation. 96:1997;2551-2556.
7. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease the Bypass Angioplasty Revascularization Investigation (BARI) . Circulation. 96:1997;1761-1769.
8. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease The Bypass Angioplasty Revascularization Investigation (BARI) Investigators . N Engl J Med. 335:1996;217-225.
9. Levine G.N., Jacobs A.K., Keeler G.P., et al. Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial. Am J Cardiol. 79:1997;748-755.
10. Weintraub W.S., Stein B., Kosinski A., et al. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol. 31:1998;10-19.
11. O'Neill W.W. Multivessel balloon angioplasty should be abandoned in diabetic patients! J Am Coll Cardiol. 31:1998;20-22.
12. ACC Expert Consensus Document Coronary artery stents . J Am Coll Cardiol. 28:1996;782-794.
13. Van Belle E., Bauters C., Hubert E., et al. Restenosis rates in diabetic patients a comparison of coronary stenting and balloon angioplasty in native coronary vessels . Circulation. 96:1997;1454-1460.
14. Ellis S.G., Savage M., Fischman D., et al. Restenosis after placement of Palmatz-Schatz stents in native coronary arteries. Initial results of a multicenter experience. Circulation. 86:1992;1836-1844.
15. Foley J.B., Penn I.M., Brown R.I., et al. Safety, success, and restenosis after elective coronary implantation of the Palmaz-Schatz stent in 100 patients at a single center. Am Heart J. 125:1993;686-694.
16. Carrozza J.P. Jr, Kuntz R.E., Fishman R.F., Baim D.S. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med. 118:1993;344-349.
17. Schömig A., Neumann F.J., Kastrati A., et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med. 334:1996;1084-1089.
18. Ellis S.G., Vandormael M.G., Cowley M.J., et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 82:1990;1193-1202.
19. Reiber J.H.C., van Land C.D., Koning G., et al. Comparison of accuracy and precision of quantitative coronary arterial analysis between cinefilm and digital systems. Reiber J.H.C., Serruys P.W. Progress in Quantitative Coronary Arteriography. 1994;67-85 Kluwer Academic Publishers, Dordrecht.
20. Harrell F.E. Jr. Predicting Outcomes Applied Survival Analysis and Logistic Regression . 1997;University of Virginia, Charlottesville.
21. Kastrati A., Schömig A., Dietz R., Neumann F.J., Richardt G. Time course of restenosis during the first year after emergency coronary stenting. Circulation. 87:1993;1498-1505.
22. Laham R.J., Carrozza J.P., Berger C., Cohen D.J., Kuntz R.E., Baim D.S. Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting paucity of late clinical stent-related problems . J Am Coll Cardiol. 28:1996;820-826.
23. Fischman D.L., Leon M.B., Baim D.S., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
24. Serruys P.W., de Jaegere P., Kiemeneij F., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease Benestent Study Group . N Engl J Med. 331:1994;489-495.
25. Davi G., Catalano I., Averna M., et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med. 322:1990;1769-1774.
26. Ostermann H., van de Loo J. Factors of the hemostatic system in diabetic patients. A survey of controlled studies. Haemostasis. 16:1986;386-416.
27. Carmassi F., Morale M., Puccetti R., et al. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res. 67:1992;643-654.
28. Schneider D.J., Nordt T.K., Sobel B.E. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes. 42:1993;1-7.
29. Johnstone M.T., Creager S.J., Scales K.M., Cusco J.A., Lee B.K., Creager M.A. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 88:1993;2510-2516.
30. Sowers J.R., Epstein M. Diabetes mellitus and hypertension an update . Hypertension. 26:1995;896-979.
31. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med. 16:1994;383-391.
32. Umeda F., Inoguchi T., Nawata H. Reduced stimulatory activity on prostacyclin production by cultured endothelial cells in serum from aged and diabetic patients. Atherosclerosis. 75:1989;61-66.
33. Betteridge D.J. Diabetic dyslipidemia. Am J Med. 96:1994;25S-31S.
34. Creager M.A., Cooke J.P., Mendelsohn M. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 86:1990;228-234.
35. Aronson D., Bloomgarden Z., Rayfield E.J. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol. 27:1996;528-535.
36. Kornowski R., Mintz G.S., Kent K.M., et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation. 95:1997;1366-1369.
37. Kuntz R.E., Keaney K.M., Senerchia C., Baim D.S. A predictive method for estimating the late angiographic results of coronary intervention despite incomplete ascertainment. Circulation. 87:1993;815-830.